Results
73,241 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Wampler Kira SchererDirector |  DOCSDoximity, Inc.Option exercise · 10b5-1 plan | M | — 2,000 sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Wampler Kira SchererDirector | DOCSDoximity, Inc. Option exercise · 10b5-1 plan | M | — 2,000 sh | Nov 4, 2026 |
| 0 | Costello Beth AnnEVP and CFO |  HIGHARTFORD INSURANCE GROUP, INC.Option exercise · 10b5-1 plan | M | — 31.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Wampler Kira SchererDirector | DOCSDoximity, Inc. Derivative conversion · 10b5-1 plan | C | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Ghamsari NimaDirector, HEAD OF BLEND |  BLNDBlend Labs, Inc.Open-market sale · 10b5-1 plan | SELL | $26K 22.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer |  RBRKRubrik, Inc.Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Santana RafaelDirector, President and CEO |  WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPOpen-market sale · 10b5-1 plan | SELL | $11K 37 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Bertolini JeffreyChief Operating Officer |  CARLCARLSMED, INC.Option exercise · 10b5-1 plan | M | — 747 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Matsuda MasaruEVP, Chief Legal Officer |  ARQTArcutis Biotherapeutics, Inc.Option exercise · 10b5-1 plan | M | — 40.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Tang StanleyDirector |  DASHDoorDash, Inc.Other acquisition or disposition · 10b5-1 plan | J | — 23.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Derivative conversion · 10b5-1 plan | C | — 2,620 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Comly Barbara J.EVP, GC & Corporate Secretary |  MIAXMIAMI INTERNATIONAL HOLDINGS, INC.Option exercise · 10b5-1 plan | M | — 8,799 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $46K 158 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | $442K 34.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Daunt JohnEVP, Chief Commercial Officer |  LQDTLIQUIDITY SERVICES INCOption exercise · 10b5-1 plan | M | — 325 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $47K 16.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Syrvalin Kristine CEVP General Counsel |  MTUSMetallus Inc.Option exercise · 10b5-1 plan | M | — 4,640 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Ticho BarryCHIEF MEDICAL OFFICER |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $5,398 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 5,786 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Option exercise · 10b5-1 plan | M | $22K 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Anderson RaymondDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | — 1,402 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 46 | Malka GabrielChief Operating Officer |  RDWRRADWARE LTDOpen-market sale | SELL | $563K 16.5K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 41 | Henson Matthew BradleyChief Accounting Officer |  CFRCULLEN/FROST BANKERS, INC.Open-market sale | SELL | $85K 534 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 40 | Regan Thomas MichaelEVP of DTS |  RRYDER SYSTEM INCOpen-market sale | SELL | $873K 3,032 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 39 | Pucheu Romero AlejandroCHIEF LEGAL COUNSEL |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $191K 52.4K sh | Nov 3, 2026 traded Nov 3, 2026 |
| 39 | Havens Thomas M.President, FMS | RRYDER SYSTEM INC Open-market sale | SELL | $1.56M 5,500 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 37 | Trivedi SurekhaSVP, Strategy & Sustainability |  VLTOVeralto CorpOpen-market sale · 10b5-1 plan | SELL | $1.08M 9,907 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 37 | Trivedi SurekhaSVP, Strategy & Sustainability | VLTOVeralto Corp Open-market sale · 10b5-1 plan | SELL | $2.89M 26.5K sh | Nov 3, 2026 traded Oct 30, 2026 |
| 37 | Nielsen Iii RobertSR VP Operations |  WCNWaste Connections, Inc.Open-market sale | SELL | $278K 1,500 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 37 | Campbell Rupert GeorgeEVP, Brand President, HEYDUDE |  CROXCrocs, Inc.Open-market sale | SELL | $399K 2,645 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 33 | Moore H Lynn JrDirector, President and CEO |  TYLTYLER TECHNOLOGIES INCOpen-market sale | SELL | $884K 2,236 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 33 | Moore H Lynn JrDirector, President and CEO | TYLTYLER TECHNOLOGIES INC Open-market sale | SELL | $453K 1,144 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 33 | Moore H Lynn JrDirector, President and CEO | TYLTYLER TECHNOLOGIES INC Open-market sale | SELL | $424K 1,080 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 33 | Moore H Lynn JrDirector, President and CEO | TYLTYLER TECHNOLOGIES INC Open-market sale | SELL | $339K 861 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 33 | Moore H Lynn JrDirector, President and CEO | TYLTYLER TECHNOLOGIES INC Open-market sale | SELL | $691K 1,752 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 33 | Moore H Lynn JrDirector, President and CEO | TYLTYLER TECHNOLOGIES INC Open-market sale | SELL | $462K 1,186 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 33 | Moore H Lynn JrDirector, President and CEO | TYLTYLER TECHNOLOGIES INC Open-market sale | SELL | $500K 1,280 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 31 | Calamos Aksia Hedged Strategies Fund (Offshore), Ltd.10% Owner | NACalamos Aksia Hedged Strategies Fund Open-market purchase | BUY | $728K 70.7K sh | Nov 3, 2026 traded Oct 30, 2026 |
| 30 | Moore H Lynn JrDirector, President and CEO | TYLTYLER TECHNOLOGIES INC Open-market sale | SELL | $179K 460 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 30 | Guarini KathrynDirector |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $360K 400 sh | Nov 3, 2026 traded Oct 30, 2026 |